The CCR2 promoter polymorphism T-960A, but not the serum MCP-1 level, is associated with endothelial function in prediabetic individuals

Atherosclerosis

Volumn 198, Issue 2, 2008, Pages 338-346

  Rittig, Kilian ^a   Peter, Andreas ^a   Baltz, Katrin M ^a   Tschritter, Otto ^a   Weigert, Cora ^a   Andreozzi, Francesco ^b   Perticone, Francesco ^b   Siegel Axel, Dorothea I ^a   Stefan, Norbert ^a   Fritsche, Andreas ^a   Salih, Helmut R ^a   Schleicher, Erwin ^a   Machicao, Fausto ^a   Sesti, Giorgio ^b   Häring, Hans Ulrich ^a   Balletshofer, Bernd M ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Endothelium; Genetics; Inflammation; MCP1 CCR2; Nitric oxide; Vasodilation

Indexed keywords

ACETYLCHOLINE; CHEMOKINE RECEPTOR CCR2; LUCIFERASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE;

ADULT; ARTICLE; BLOOD FLOW; CELL MIGRATION; CONFOUNDING VARIABLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNIC DIFFERENCE; FEMALE; GEL MOBILITY SHIFT ASSAY; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; IN VIVO STUDY; ITALY; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; STATISTICAL SIGNIFICANCE; VASODILATATION;

ADULT; ATHEROSCLEROSIS; BLOOD CIRCULATION; CELL MOVEMENT; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTHELIUM, VASCULAR; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; LUCIFERASES; MALE; MIDDLE AGED; MONOCYTES; POLYMORPHISM, GENETIC; PREDIABETIC STATE; PROMOTER REGIONS (GENETICS); RECEPTORS, CCR2; VASODILATION;

EID: 43949083417     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.10.028     Document Type: Article

References (33)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
2. Caballero A.E. Metabolic and vascular abnormalities in subjects at risk for type 2 diabetes: the early start of a dangerous situation. Arch Med Res 36 (2005) 241-249
3. Premack B.A., and Schall T.J. Chemokine receptors: gateways to inflammation and infection. Nat Med 2 (1996) 1174-1178
4. Ni W., Egashira K., Kitamoto S., et al. New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice. Circulation 103 (2001) 2096-2101
5. Dawson T.C., Kuziel W.A., Osahar T.A., and Maeda N. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 143 (1999) 205-211
6. Guo J, Van Eck M, de W V, et al. The presence of leukocyte CC-chemokine receptor 2 in CCR2 knockout mice promotes atherogenesis. Biochim Biophys Acta 2005;1740:453-9.
7. Flaishon L., Becker-Herman S., Hart G., Levo Y., Kuziel W.A., and Shachar I. Expression of the chemokine receptor CCR2 on immature B cells negatively regulates their cytoskeletal rearrangement and migration. Blood 104 (2004) 933-941
8. de Lemos J.A., Morrow D.A., Sabatine M.S., et al. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 107 (2003) 690-695
9. Spieker L.E., and Luscher T.F. Protection of endothelial function. Handb Exp Pharmacol (2005) 619-644
10. Schachinger V., Britten M.B., and Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long- term outcome of coronary heart disease. Circulation 101 (2000) 1899-1906
11. Gokce N., Keaney Jr. J.F., Hunter L.M., Watkins M.T., Menzoian J.O., and Vita J.A. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation 105 (2002) 1567-1572
12. Suwaidi J.A., Hamasaki S., Higano S.T., Nishimura R.A., Holmes Jr. D.R., and Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101 (2000) 948-954
13. Balletshofer B.M., Rittig K., Enderle M.D., et al. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation 101 (2000) 1780-1784
14. Perticone F., Sciacqua A., Maio R., et al. Asymmetric dimethylarginine, l-arginine, and endothelial dysfunction in essential hypertension. J Am Coll Cardiol 46 (2005) 518-523
15. Celermajer D.S., Sorensen K.E., Gooch V.M., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340 (1992) 1111-1115
16. Joannides R., Haefeli W.E., Linder L., et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 91 (1995) 1314-1319
17. Wendelhag I., Gustavsson T., Suurkula M., Berglund G., and Wikstrand J. Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing system. Clin Physiol 11 (1991) 565-577
18. Panza J.A., Quyyumi A.A., Brush Jr. J.E., and Epstein S.E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension [see comments]. N Engl J Med 323 (1990) 22-27
19. Matsuda M., and DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diab Care 22 (1999) 1462-1470
20. Andrews N.C., and Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19 (1991) 2499
21. Yamamoto K., Takeshima H., Hamada K., et al. Cloning and functional characterization of the 5′-flanking region of the human monocyte chemoattractant protein-1 receptor (CCR2) gene. Essential role of 5′-untranslated region in tissue-specific expression. J Biol Chem 274 (1999) 4646-4654
22. Axel D.I., Spyridopoulos I., Riessen R., Runge H., Viebahn R., and Karsch K.R. Toxicity, uptake kinetics and efficacy of new transfection reagents: increase of oligonucleotide uptake. J Vasc Res 37 (2000) 221-234
23. Phillips R.J., Lutz M., and Premack B. Differential signaling mechanisms regulate expression of CC chemokine receptor-2 during monocyte maturation. J Inflamm (Lond) 2 (2005) 14
24. Hauk P.J., Hamid Q.A., Chrousos G.P., and Leung D.Y. Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. J Allergy Clin Immunol 105 (2000) 782-787
25. Hu Q., Frank I., Williams V., et al. Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue. J Exp Med 199 (2004) 1065-1075
26. Hafsi N., Voland P., and Schwendy. S et al. Human dendritic cells respond to Helicobacter pylori, promoting NK cell and Th1-effector responses in vitro. J Immunol 173 (2004) 1249-1257
27. Kielbassa K., Schmitz C., and Gerke V. Disruption of endothelial microfilaments selectively reduces the transendothelial migration of monocytes. Exp Cell Res 243 (1998) 129-141
28. Tickenbrock L., Schwable J., Strey A., et al. Wnt signaling regulates transendothelial migration of monocytes. J Leukoc Biol 79 (2006) 1306-1313
29. Tregouet D.A., Escolano S., Tiret L., Mallet A., and Golmard J.L. A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm. Ann Hum Genet 68 (2004) 165-177
30. Nelken N.A., Coughlin S.R., Gordon D., and Wilcox J.N. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 88 (1991) 1121-1127
31. Bruun J.M., Lihn A.S., Pedersen S.B., and Richelsen B. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab 90 (2005) 2282-2289
32. Charo I.F., and Taubman M.B. Chemokines in the pathogenesis of vascular disease. Circ Res 95 (2004) 858-866
33. Maslin C.L., Kedzierska K., Webster N.L., Muller W.A., and Crowe S.M. Transendothelial migration of monocytes: the underlying molecular mechanisms and consequences of HIV-1 infection. Curr HIV Res 3 (2005) 303-317